← back to search

Christine Walsh

University of Colorado Hospital ·
🔎 Find collaborators in Reproductive Medicine · Genetics →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Reproductive Medicine · Genetics
Research interest
Research interests include Ovarian cancer diagnosis and treatment, BRCA gene mutations in cancer, Endometrial and Cervical Cancer Treatments, and PARP inhibition in cancer therapy.
h-index
42
citations
7,877
works
295
NIH funding
primary concept
Medicine
email

Recent publications

A multi-level investigation of the genetic relationship between endometriosis and ovarian cancer histotypes
Cell Reports Medicine 2022cited by 58position: middledoi
DNA methylation and transcriptomic features are preserved throughout disease recurrence and chemoresistance in high grade serous ovarian cancers
Journal of Experimental & Clinical Cancer Research 2022cited by 19position: middledoi
Phase II trial of cisplatin, gemcitabine and pembrolizumab for platinum-resistant ovarian cancer.
2021cited by 19position: contributordoi
A multi-level investigation of the genetic relationship between endometriosis and ovarian cancer histotypes
medRxiv 2021cited by 8position: middledoi
PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline.
2020cited by 217position: contributordoi
Abnormal mismatch repair and other clinicopathologic predictors of poor response to progestin treatment in young women with endometrial complex atypical hyperplasia and well‐differentiated endometrial adenocarcinoma: a consecutive case series
BJOG An International Journal of Obstetrics & Gynaecology 2017cited by 66position: lastdoi
Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci
British Journal of Cancer 2017cited by 28position: middledoi
Three versus six cycles of adjuvant platinum-based chemotherapy in early stage clear cell ovarian carcinoma – A multi-institutional cohort
Gynecologic Oncology 2016cited by 43position: lastdoi
Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian Cancer
JAMA 2015cited by 502position: middledoi
Staging Lymphadenectomy in Patients With Clear Cell Carcinoma of the Ovary
International Journal of Gynecological Cancer 2015cited by 40position: middledoi
Assessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation Carriers
PLoS ONE 2015cited by 39position: middledoi
ABCA Transporter Gene Expression and Poor Outcome in Epithelial Ovarian Cancer
JNCI Journal of the National Cancer Institute 2014cited by 228position: middledoi
Germline Mutation in <i>BRCA1</i> or <i>BRCA2</i> and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian Cancer
Clinical Cancer Research 2014cited by 160position: middledoi
DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
PLoS Genetics 2014cited by 130position: middledoi
Cyclin E1 and RTK/RAS signaling drive CDK inhibitor resistance via activation of E2F and ETS
Oncotarget 2014cited by 119position: middledoi
Evaluating the ovarian cancer gonadotropin hypothesis: A candidate gene study
Gynecologic Oncology 2014cited by 19position: middledoi
Variation in NF-κB Signaling Pathways and Survival in Invasive Epithelial Ovarian Cancer
Cancer Epidemiology Biomarkers & Prevention 2014cited by 15position: middledoi
Consortium analysis of gene and gene–folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk
Molecular Nutrition & Food Research 2014cited by 12position: middledoi
POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer
Gynecologic Oncology 2013cited by 108position: middledoi
Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA
Human Genetics 2013cited by 26position: middledoi
Analysis of Over 10,000 Cases Finds No Association between Previously Reported Candidate Polymorphisms and Ovarian Cancer Outcome
Cancer Epidemiology Biomarkers & Prevention 2013cited by 23position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Beth Y. Karlan · South Carolina Department of Health and Environmental Control5 papers (2013–2022)Kathleen N. Moore · Oklahoma City University3 papers (2015–2020)Kate Lawrenson · Texas A&M University – San Antonio3 papers (2021–2022)Ilana Cass · Dartmouth College3 papers (2021–2022)B.J. Rimel · University of Louisville3 papers (2021–2022)Simon A. Gayther · MRC Clinical Trials Unit at UCL3 papers (2021–2022)Matthew T. Siedhoff · Twitter (United States)2 papers (2021–2022)Siddhartha Kar · University of Cambridge2 papers (2021–2022)Sandra Oršulić · University of California, Los Angeles2 papers (2013–2014)Sally Mortlock · University of Queensland2 papers (2021–2022)Matthew L. Freedman · Harvard University2 papers (2021–2022)Paul D.P. Pharoah · University of Thessaly2 papers (2021–2022)Jenny Lester · University of California, Los Angeles2 papers (2013–2022) · 2 papers (2021–2022)Camille C. Gunderson · University of Oklahoma Health Sciences Center2 papers (2015–2016) · 2 papers (2020–2021)Charles A. Leath · St. Vincent's Birmingham2 papers (2015–2016) · 2 papers (2015–2016)Britt Erickson · University of Alabama at Birmingham2 papers (2015–2016)Ji-Heui Seo · Harvard University2 papers (2021–2022)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Reproductive Medicine · Genetics →